Hisamitsu Pharmaceutical Co., Inc.

TSE:4530.T

3948 (JPY) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Operating Activities:
Net Income 13,97016,11312,95612,19726,15525,67327,69429,98427,92229,41633,72731,99132,37936,10431,84832,20830,20625,91724,50721,898
Depreciation & Amortization 5,1724,9524,3214,0794,2515,7426,0057,3688,5457,6137,4927,5936,8997,1537,6246,8795,5435,2245,2933,314
Deferred Income Tax 00000000000000000000
Stock Based Compensation 00000000000000000000
Change In Working Capital -1,314-2624,291-2,395-1,388-4,8702,763-5,5952,494-3,8683,932-275-4252,584-4,865-5,282-763-7,9152,3191,997
Accounts Receivables -2,0827802,1918,955-9,422-5,3106671,3718,626-8,506571-3,06800000000
Inventory -1,628-1,5813,073-4,3252321,310485-2,262-605370-1,365-754-2,168702-1,279-784279-391-2,098-665
Accounts Payables 686653-2,196-3,8124,944649-316421-3,86800000000000
Other Working Capital 1,710-1141,223-3,2132,858-1,5192,278-3,3333,099-4,2385,2974791,7431,882-3,586-4,498-1,042-7,5244,4172,662
Other Non Cash Items 13,728-8,076-2,369-8,592-1,623-10,773-6,009-11,847-8,038-9,929-9,306-6,824-13,295-9,499-14,109-11,423-9,264-10,998-9,005-7,079
Operating Cash Flow 18,18812,72719,1995,28927,39515,77230,45319,91030,92323,23235,84532,48525,55836,34220,49822,38225,72212,22823,11420,130
Investing Activities:
Investments In Property Plant And Equipment -13,036-7,908-4,193-3,388-3,726-3,663-3,340-3,199-5,149-4,871-4,208-5,635-15,779-6,164-7,050-5,986-9,562-5,641-4,977-2,297
Acquisitions Net -6,614957-54459774-247-1213,2671,952236-99-610-5,91627-89-1,302-1,1976-11,983200
Purchases Of Investments -15-5,897-340-191-11,129-883-691-493-2,543-3,867-1,886-2,730-3,735-2,428-38,256-15,352-10,620-9,654-1,549-3,264
Sales Maturities Of Investments 17,1241,9992,44010,926-741,8982,887912-328351,04532341896,5529,3128,4615,634819950
Other Investing Activites 27-13,019-10,423-129-2,374-36,407-1135831,860-1,278-6951,0269,7231286,296-2,5991,007-2,149-916-344
Investing Cash Flow -2,512-23,868-13,0607,815-17,229-39,302-1,3781,070-3,912-8,945-5,843-7,946-15,473-8,248-32,547-15,927-11,911-11,804-18,606-4,755
Financing Activities:
Debt Repayment -70-71-77-69-67-71-71-78-370-137-243-2,803-5,401-5,216-2,731-279-2,677-5,200-3,303-582
Common Stock Issued 0-61-84-215-204-168-1591157-59-601,881219,398321-232010,399662
Common Stock Repurchased -9,796-7,694-8,043-2-4,520-6,176-2-11,153-4,178-1-30-3,317-3-5,948-66-8-9-5,764-75
Dividends Paid -6,578-6,719-6,839-6,806-6,836-6,882-6,855-6,944-7,067-6,642-5,998-6,000-6,031-5,980-5,773-5,433-4,790-4,689-1,633-1,270
Other Financing Activities -244-142-146-95-99-50-66-228-158-197-226-485-142-4,462-47-10-2-2-2-2
Financing Cash Flow -16,691-14,687-15,189-7,187-11,726-13,347-7,153-18,402-11,616-7,036-6,476-9,288-13,010-15,6594,899-5,467-7,479-9,580-303-1,267
Other Information:
Effect Of Forex Changes On Cash 1,9575,0053,944-1,559-225-908-963-909-673,5823,3941,387-506-1,01125-337-13543150-47
Net Change In Cash -11,503-20,823-5,1074,358-1,786-37,78720,9591,67015,32610,83426,92016,638-3,43211,422-7,1246506,196-9,1134,14614,060
Cash At End Of Period 53,92165,42486,24791,35486,99688,782126,569105,610103,94088,61477,78050,86034,22237,65426,23233,35632,70626,51035,62331,477